Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy Sterne, J. A.; May, M.; Bucher, H. C.; Ledergerber, Bruno; ... Egger, M. 2007
add to browser selection
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy Arnedo, Mireia; Taffe, Patrick; Sahli, Roland; Furrer, Hansjakob; ... Tarr, P. E. 2007
add to browser selection
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders Tarr, P. E.; Taffe, Patrick; Bleiber, Gabriela; Furrer, Hansjakob; ... Telenti, Amalio 2005
add to browser selection
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study Hasse, Barbara; Ledergerber, Bruno; Egger, Mathias; Egger, Martin; ... Gunthard, Huldrych 2004
add to browser selection
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio 2002
add to browser selection
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Fellay, Jacques; Boubaker, K.; Ledergerber, Bruno; Bernasconi, Enos; ... Telenti, A. 2001
add to browser selection
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study Boubaker, K.; Flepp, Markus; Sudre, Philippe; Furrer, Hansjakob; ... Telenti, A. 2001